Bioinformatics-based Identification of Key Pathways and Hub Genes of Traumatic Brain Injury in a Rat Model

Abstract

Traumatic brain injury (TBI) is a common injury caused by external forces that lead to damaged brain function or pathological changes in the brain tissue. To explore the molecular mechanism and the hub genes of TBI, we downloaded gene expression profiles of the TBI model of rat and the sham control for the subsequent gene set enrichment analysis, pathway analysis and protein-protein interactions analysis. The results of Gene Ontology and Kyoto Encyclopedia of Genes and Genomes analysis indicated that multiple biological pathways, including immune response, inflammatory response and cellular response to interleukin-1, as well as signaling pathways, such as tumor necrosis factor signaling pathway, chemokine signaling pathway, cytokine-cytokine receptor interaction, Toll-like receptor signaling pathway and nuclear factor kappa B signaling pathway were implicated in the TBI. In conclusion, this study provides insights into the molecular mechanism of TBI by screening the differentially expressed genes and hub genes that can be used as biomarkers and therapeutic targets.

Keywords

traumatic brain injury / bioinformatics analysis / differentially expressed gene / hub gene / signal pathway

References

[1] MenonDK, SchwabK, WrightDW, et al.. Position statement: definition of traumatic brain injury. Arch Phys Med Rehabil, 2010, 91(11): 1637-1640

[2] MaasAIR, MenonDK, AdelsonPD, et al.. Traumatic brain injury: integrated approaches to improve prevention, clinical care, and research. Lancet Neurol, 2017, 16(12): 987-1048

[3] HinzmanJM, ThomasTC, BurmeisterJJ, et al.. Diffuse brain injury elevates tonic glutamate levels and potassium-evoked glutamate release in discrete brain regions at two days post-injury: an enzyme-based microelectrode array study. J Neurotrauma, 2010, 27(5): 889-899

[4] NikolianVC, DekkerSE, BambakidisT, et al.. Improvement of Blood-Brain Barrier Integrity in Traumatic Brain Injury and Hemorrhagic Shock Following Treatment With Valproic Acid and Fresh Frozen Plasma. Crit Care Med, 2018, 46(1): e59-e66

[5] LoaneDJ, FadenAI. Neuroprotection for traumatic brain injury: translational challenges and emerging therapeutic strategies. Trends Pharmacol Sci, 2010, 31(12): 596-604

[6] HuiJ, LiuR, ZhangH, et al.. Screening and identification of critical biomarkers in erectile dysfunction: evidence from bioinformatic analysis. PeerJ, 2020, 8: e8653

[7] ShojoH, BorlonganCV, MabuchiT. Genetic and Histological Alterations Reveal Key Role of Prostaglandin Synthase and Cyclooxygenase 1 and 2 in Traumatic Brain Injury-Induced Neuroinflammation in the Cerebral Cortex of Rats Exposed to Moderate Fluid Percussion Injury. Cell Transplant, 2017, 26(7): 1301-1313

[8] BarrettT, TroupDB, WilhiteSE, et al.. NCBI GEO: archive for functional genomics data sets—10 years on. Nucleic Acids Res, 2011, 39: D1005-D1010

[9] ShojoH, KanekoY, MabuchiT, et al.. Genetic and histologic evidence implicates role of inflammation in traumatic brain injury-induced apoptosis in the rat cerebral cortex following moderate fluid percussion injury. Neuroscience, 2010, 171(4): 1273-1282

[10] HuberW, CareyVJ, GentlemanR, et al.. Orchestrating high-throughput genomic analysis with Bioconductor. Nat Methods, 2015, 12(2): 115-121

[11] BlakeJA, ChanJ, KishoreR, et al.. Gene Ontology Consortium: going forward. Nucleic Acids Research, 2015, 43: D1049-D1056

[12] KanehisaM, GotoS, FurumichiM, et al.. KEGG for representation and analysis of molecular networks involving diseases and drugs. Nucleic Acids Res, 2010, 38: D355-D360

[13] KoteraM, HirakawaM, TokimatsuT, et al.. The KEGG databases and tools facilitating omics analysis: latest developments involving human diseases and pharmaceuticals. Methods Mol Biol, 2012, 802: 19-39

[14] HuangDW, ShermanBT, TanQ, et al.. DAVID Bioinformatics Resources: expanded annotation database and novel algorithms to better extract biology from large gene lists. Nucleic Acids Res, 2007, 35: W169-W175

[15] HuangDW, ShermanBT, LempickiRA. Systematic and integrative analysis of large gene lists using DAVID bioinformatics resources. Nat Protoc, 2008, 4(1): 44-57

[16] SzklarczykD, FranceschiniA, WyderS, et al.. STRING v10: protein-protein interaction networks, integrated over the tree of life. Nucleic Acids Res, 2015, 43: D447-D452

[17] ShannonP. Cytoscape: A Software Environment for Integrated Models of Biomolecular Interaction Networks. Genome Res, 2003, 13(11): 2498-2504

[18] GodoyDA, LubilloS, RabinsteinAA. Pathophysiology and Management of Intracranial Hypertension and Tissular Brain Hypoxia After Severe Traumatic Brain Injury: An Integrative Approach. Neurosurg Clin N Am, 2018, 29(2): 195-212

[19] Monson KennethL, Converse MatthewI, Manley GeoffreyT. Cerebral blood vessel damage in traumatic brain injury. Clin Biomech (Bristol Avon), 2019, 64: 98-113

[20] AnghinahR, AmorimRLO, PaivaWS, et al.. Traumatic brain injury pharmacological treatment: recommendations. Arquivos de Neuro-Psiquiatria, 2018, 76(2): 100-103

[21] Abou El FadlMH, O’PhelanKH. Management of Traumatic Brain Injury: An Update. Neurosurg Clin N Am, 2018, 29(2): 213-221

[22] GoodwinS, McphersonJD, MccombieWR. Coming of age: ten years of next-generation sequencing technologies. Nat Rev Genet, 2016, 17(6): 333-351

[23] van DamS, CraigT, de MagalhñesJP. GeneFriends: a human RNA-seq-based gene and transcript co-expression database. Nucleic Acids Res, 2015, 43: D1124-D1132

[24] MiaoM, De ClercqE, LiG. Clinical significance of chemokine receptor antagonists. Expert Opin Drug Metab Toxicol, 2020, 16(1): 11-30

[25] WoodcockT, Morganti-KossmannMC. The role of markers of inflammation in traumatic brain injury. Front Neurol, 2013, 4: 18

[26] FörstnerP, RehmanR, AnastasiadouS, et al.. Neuroinflammation after Traumatic Brain Injury Is Enhanced in Activating Transcription Factor 3 Mutant Mice. J Neurotrauma, 2018, 35(19): 2317-2329

[27] SempleBD, ByeN, RancanM, et al.. Role of CCL2 (MCP-1) in traumatic brain injury (TBI): evidence from severe TBI patients and CCL2-/- mice. J Cereb Blood Flow Metab, 2010, 30(4): 769-782

[28] WoodcockTM, FrugierT, NguyenTT, et al.. The scavenging chemokine receptor ACKR2 has a significant impact on acute mortality rate and early lesion development after traumatic brain injury. PLoS One, 2017, 12: e0188305

[29] SempleBD, ByeN, ZiebellJM, et al.. Deficiency of the chemokine receptor CXCR2 attenuates neutrophil infiltration and cortical damage following closed head injury. Neurobiol Dis, 2010, 40(2): 394-403

[30] ZiebellJM, Morganti-KossmannMC. Involvement of pro- and anti-inflammatory cytokines and chemokines in the pathophysiology of traumatic brain injury. Neurotherapeutics, 2010, 7(1): 22-30

[31] WangQ, TangXN, YenariMA. The inflammatory response in stroke. J Neuroimmunol, 2007, 184(1–2): 53-68

[32] TuttolomondoA, PecoraroR, PintoA. Studies of selective TNF inhibitors in the treatment of brain injury from stroke and trauma: a review of the evidence to date. Drug Des Devel Ther, 2014, 8: 2221-38

[33] FeldmanN, Rotter-MaskowitzA, OkunE. DAMPs as mediators of sterile inflammation in aging-related pathologies. Ageing Res Rev, 2015, 24(PtA): 29-39

[34] ChiuCC, LiaoYE, YangLY, et al.. Neuroinflammation in animal models of traumatic brain injury. J Neurosci Methods, 2016, 272: 38-49

[35] HuaF, MaJ, HaT, et al.. Activation of Toll-like receptor 4 signaling contributes to hippocampal neuronal death following global cerebral ischemia/reperfusion. J Neuroimmunol, 2007, 190(1–2): 101-111

[36] YuN, HuS, HaoZ. Benificial Effect of Stachydrine on the Traumatic Brain Injury Induced Neurodegeneration by Attenuating the Expressions of Akt/mTOR/PI3K and TLR4/NFκ-B Pathway. Transl Neurosci, 2018, 9: 175-182

[37] SimonDW, McGeachyMJ, BayirH, et al.. The far-reaching scope of neuroinflammation after traumatic brain injury. Nat Rev Neurol, 2017, 13(3): 171-191

[38] KnoblachSM, FanL, FadenAI. Early neuronal expression of tumor necrosis factor-alpha after experimental brain injury contributes to neurological impairment. J Neuroimmunol, 1999, 95(1–2): 115-125

[39] PachterJS, De VriesHE, FabryZ. The Blood-Brain Barrier and Its Role in Immune Privilege in the Central Nervous System. J Neuropathol Exp Neurol, 2003, 62(6): 593-604

[40] SebireG, HeryC, PeudenierS, et al.. Adhesion proteins on human microglial cells and modulation of their expression by IL1α and TNFα. Res Virol, 1993, 144(1): 47-52

[41] ChodobskiA, ZinkBJ, Szmydynger-ChodobskaJ. Blood-Brain Barrier Pathophysiology in Traumatic Brain Injury. Transl Stroke Res, 2011, 2(4): 492-516

[42] PleinesUE, StoverJF, KossmannT, et al.. Soluble ICAM-1 in CSF coincides with the extent of cerebral damage in patients with severe traumatic brain injury. J Neurotrauma, 1998, 15(6): 399-409

[43] HabgoodMD, ByeN, DziegielewskaKM, et al.. Changes in blood-brain barrier permeability to large and small molecules following traumatic brain injury in mice. Eur J Neurosci, 2007, 25(1): 231-238

[44] HuaF, WangJ, IshratT, et al.. Genomic profile of Toll-like receptor pathways in traumatically brain-injured mice: effect of exogenous progesterone. J Neuroinflammation, 2011, 8: 42

[45] ZhuHT, BianC, YuanJC, et al.. Curcumin attenuates acute inflammatory injury by inhibiting the TLR4/MyD88/NF-κB signaling pathway in experimental traumatic brain injury. J Neuroinflammation, 2014, 11: 59

[46] LucasK, MaesM. Role of the Toll Like Receptor (TLR) Radical Cycle in Chronic Inflammation: Possible Treatments Targeting the TLR4 Pathway. Mol Neurobiol, 2013, 48(1): 190-204

[47] ParkC, ChoIH, KimD, et al.. Toll-like receptor 2 contributes to glial cell activation and heme oxygenase-1 expression in traumatic brain injury. Neurosci Lett, 2008, 431(2): 123-128

[48] YuZQ, ZhaJH. Genetic ablation of toll-like receptor 2 reduces secondary brain injury caused by cortical contusion in mice. Ann Clin Lab Sci, 2012, 42(1): 26-33